Legal Representation
Attorney
Karen Won
USPTO Deadlines
Next Deadline
26 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20200218)
Due Date
February 18, 2026
Grace Period Ends
August 18, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
42 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 31, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Dec 31, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Dec 31, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Dec 31, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Dec 31, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Feb 18, 2025 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Feb 18, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jan 14, 2020 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Jan 13, 2020 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Dec 30, 2019 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Dec 18, 2019 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Dec 28, 2019 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Dec 18, 2019 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Dec 12, 2019 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Dec 12, 2019 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Oct 2, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 30, 2019 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Sep 30, 2019 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Sep 30, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 10, 2019 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Mar 30, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 28, 2019 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Mar 28, 2019 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Mar 28, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 3, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 1, 2018 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 1, 2018 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 1, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 3, 2018 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Feb 6, 2018 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 6, 2018 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 17, 2018 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 1, 2018 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Dec 14, 2017 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 14, 2017 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Dec 14, 2017 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 14, 2017 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 14, 2017 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Dec 12, 2017 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 14, 2017 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Sep 13, 2017 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 11, 2017 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical and biopharmaceutical preparations for the treatment of cancer
First Use Anywhere:
Dec 9, 2019
First Use in Commerce:
Dec 9, 2019
Class 042
Scientific research and development for medical, pharmaceutical, and biopharmaceutical purposes; consulting in the field of medical, pharmaceutical, and biopharmaceutical research and product development; conducting of clinical trials, for others and development of pharmaceutical products, biopharmaceutical products, and other therapeutic products; development of cancer vaccines and treatment products for cancer
First Use Anywhere:
20170900
First Use in Commerce:
20170900
Additional Information
Design Mark
The mark consists of the wording "SELLAS" in stylized dark blue font, appearing on top of the wording "LIFE SCIENCES GROUP" in stylized dark blue font and a light blue rectangular shape with round edges, containing white diagonal stripes with a white dash between the second and third diagonal strip and a white dash between the fifth and sixth diagonal stripe inside said shape, positioned to the left of the wording "LIFE SCIENCES GROUP".
Color Claim
The color(s) white, dark blue, and light blue is/are claimed as a feature of the mark.
Translation
The English Translation of the word "SELLAS" in the mark is "STAMP" or "SEAL"
Classification
International Classes
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"LIFE SCIENCES GROUP"